| Family: | Goldman Sachs |
| Name: | Goldman Sachs Future Health Care Equity ETF |
| Inception Date: | 9-Nov-2021 |
| Termination Date: | |
| Investment Objective: | The Fund generally intends to invest in companies that the Investment Adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare (the Key Themes ). |
| Prospectus | |
| Top 10 Holdings | ||
| ELI LILLY & CO | LLY | 12.1035% |
| JOHNSON & JOHNSON | JNJ | 8.6186% |
| MERCK & CO. INC. | MRK | 7.5894% |
| UNITEDHEALTH GROUP INCORPORATED | UNH | 5.8985% |
| VERTEX PHARMACEUTICALS INCORPORATED | VRTX | 4.2593% |
| ARGENX SE-ADR | ARGX | 4.1886% |
| GUARDANT HEALTH INC. | GH | 4.0289% |
| DEXCOM INC. | DXCM | 3.7695% |
| THERMO FISHER SCIENTIFIC INC | TMO | 3.4805% |
| EDWARDS LIFESCIENCES CORPORATION | EW | 3.4059% |
| Top 10 Holdings Weight: | 57.3% |
| Number of Holdings: | 44 |
| Shares Outstanding: | 525,000 |
| Total Net Assets: | 19,788,404 |
| NAV: | 37.69 |
| Net Expense Ratio: | 0.75% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Funds Combining Developed & Emerging Exposure |
| Country: | |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Global |
